Stay updated on Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA 403 Forbidden error page now appears, replacing the full study record and preventing viewing the trial details. The error page shows a minimal header with 403 Forbidden, indicating an access issue rather than content.SummaryDifference19%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the record rather than changes to the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer release of the study record's metadata.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small backend/template update to the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's documentation/versioning, with no indicated changes to core content.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page now shows a new revision tag (v3.6.2) replacing the old v3.6.0 tag. This reflects a minor update to the page's software version without changing the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Avutometinib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Combo in KRAS G12C NSCLC Clinical Trial page.